Literature DB >> 30168085

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.

Amy Paller1, Jennifer C Jaworski2, Eric L Simpson3, Mark Boguniewicz4, John J Russell5, Julie K Block6, Susan Tofte7, Jeffrey D Dunn8, Steven R Feldman9, Adele R Clark9, Gene Schwartz10, Lawrence F Eichenfield11.   

Abstract

The consequences of atopic dermatitis reach beyond the skin and past childhood. Patients with atopic dermatitis are at risk of developing allergic comorbidities, but less is known about the associations between atopic dermatitis and non-allergic conditions. Understanding these non-allergic comorbidities has the potential to improve patient outcomes and to help mitigate the cost and burdens associated with these conditions. Atopic dermatitis is associated with cutaneous bacterial infections, more severe forms/courses of cutaneous viral infections, and extra-cutaneous infections. Atopic dermatitis is also associated with several mental health comorbidities particularly attention-deficit hyperactivity disorder, anxiety, and depression. Data are largely inconsistent for specific cancers, but atopic dermatitis appears to protect against malignancy overall; severe long-term atopic dermatitis is associated with adult lymphomas. Atopic dermatitis may also be associated with obesity, cardiovascular disease, and autoimmune disease, particularly alopecia areata and gastrointestinal immune-mediated disorders. Although the causative mechanisms underlying these associations are poorly understood, treating physicians should be aware of associations in seeking to alleviate the burden for patients with atopic dermatitis.

Entities:  

Mesh:

Year:  2018        PMID: 30168085     DOI: 10.1007/s40257-018-0383-4

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  29 in total

1.  Study protocol: assessing SleeP IN infants with early-onset atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study).

Authors:  Cathal O'Connor; Alan D Irvine; Deirdre Murray; Michelle Murphy; Jonathan O'B Hourihane; Geraldine Boylan
Journal:  BMC Pediatr       Date:  2022-06-18       Impact factor: 2.567

2.  Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis.

Authors:  Carolina Cabalín; Guillermo Pérez-Mateluna; Carolina Iturriaga; Carlos A Camargo; Arturo Borzutzky
Journal:  Arch Dermatol Res       Date:  2022-10-22       Impact factor: 3.033

Review 3.  Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis.

Authors:  Nan Yang; Zeyu Chen; Xilin Zhang; Yuling Shi
Journal:  BioDrugs       Date:  2021-07-02       Impact factor: 5.807

4.  Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis.

Authors:  Atsuyuki Igarashi; Hiroyuki Fujita; Kazuhiko Arima; Tomoyuki Inoue; Julie Dorey; Ayako Fukushima; Yurie Taguchi
Journal:  J Dermatol       Date:  2019-06-27       Impact factor: 4.005

5.  Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey.

Authors:  Joaquín Sastre; Esther Serra Baldrich; José Carlos Armario Hita; L Herráez; Ignacio Jáuregui; Ana Martín-Santiago; Javier Ortiz de Frutos; Juan Francisco Silvestre; Antonio Valero
Journal:  Dermatol Res Pract       Date:  2020-04-07

Review 6.  Nanotechnology meets atopic dermatitis: Current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature.

Authors:  Giovanni Damiani; Roberto Eggenhöffner; Paolo Daniele Maria Pigatto; Nicola Luigi Bragazzi
Journal:  Bioact Mater       Date:  2019-12-02

7.  Atopic Eczema in Adulthood and Risk of Depression and Anxiety: A Population-Based Cohort Study.

Authors:  Yochai Schonmann; Kathryn E Mansfield; Joseph F Hayes; Katrina Abuabara; Amanda Roberts; Liam Smeeth; Sinéad M Langan
Journal:  J Allergy Clin Immunol Pract       Date:  2019-08-31

Review 8.  Interventions to improve primary care provider management of atopic dermatitis: A systematic review.

Authors:  Emily A Croce; Fabiana C P S Lopes; Jennifer Ruth; Jonathan I Silverberg
Journal:  Pediatr Dermatol       Date:  2021-07-14       Impact factor: 1.997

9.  Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.

Authors:  Amy S Paller; Ashish Bansal; Eric L Simpson; Mark Boguniewicz; Andrew Blauvelt; Elaine C Siegfried; Emma Guttman-Yassky; Thomas Hultsch; Zhen Chen; Paola Mina-Osorio; Yufang Lu; Ana B Rossi; Xinyi He; Mohamed Kamal; Neil M H Graham; Gianluca Pirozzi; Marcella Ruddy; Laurent Eckert; Abhijit Gadkari
Journal:  Am J Clin Dermatol       Date:  2020-02       Impact factor: 7.403

10.  Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes.

Authors:  Qian-Nan Jia; Yue-Ping Zeng
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.